Physician

Vickas Khemsara, MD

According to 2025 Medicare claims, Vickas Khemsara, MD (NPI: 1477557023) practices ophthalmology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is SUMMIT EYE CARE, P.A. (NPI: 1992932016; TIN: 263230326) and primary practice location at 27103-3207.

Khemsara's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 857 traditional Medicare patients, billed 4,121 HCPCS/CPT codes, and received $357,785 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,052 prescription claims across 1,584 beneficiaries totaling $623,016 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 11 records totaling $298. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$266K$531K2015 Medicare payment: $396,848 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $468,619 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $513,469 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $518,175 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $531,178 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $428,793 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $507,097 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $459,627 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $339,518 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $357,785 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1755,378$396,848
20161,3287,131$468,619
20171,2718,168$513,469
20181,2188,238$518,175
20191,2358,099$531,178
20201,0005,904$428,793
20211,0085,460$507,097
20221,0425,064$459,627
20239814,227$339,518
20248574,121$357,785

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$576K$1.2M2015 Drug cost: $575,406 (USD; Tot_Drug_Cst)2016 Drug cost: $733,056 (USD; Tot_Drug_Cst)2017 Drug cost: $886,113 (USD; Tot_Drug_Cst)2018 Drug cost: $969,891 (USD; Tot_Drug_Cst)2019 Drug cost: $986,584 (USD; Tot_Drug_Cst)2020 Drug cost: $960,469 (USD; Tot_Drug_Cst)2021 Drug cost: $1,069,181 (USD; Tot_Drug_Cst)2022 Drug cost: $1,151,675 (USD; Tot_Drug_Cst)2023 Drug cost: $1,009,593 (USD; Tot_Drug_Cst)2024 Drug cost: $623,016 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,3026,845$575,406
20161,4247,311$733,056
20171,5408,283$886,113
20181,7098,542$969,891
20191,7218,473$986,584
20201,6007,917$960,469
20211,7437,846$1,069,181
20221,8218,120$1,151,675
20231,7427,850$1,009,593
20241,5847,052$623,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more562689$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more207277$64
92083Exam of visual field with extended testing172189$45
92134Imaging of retina410510$28
92133Imaging of optic nerve200257$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine18612,165$246,959
LumiganBimatoprost1779,202$80,575
Prednisolone AcetatePrednisolone Acetate1,19423,831$35,411
CombiganBrimonidine Tartrate/Timolol1093,990$26,536
XiidraLifitegrast181,080$24,787

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$298Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vickas Khemsara, MD?

Tedicare shows public-source Medicare data for Vickas Khemsara, MD (NPI 1477557023), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vickas Khemsara, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vickas Khemsara, MD?

Vickas Khemsara, MD is linked to SUMMIT EYE CARE, P.A. (billing NPI 1992932016) in the available physician profile data.

Does Vickas Khemsara, MD have Open Payments data?

Vickas Khemsara, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.